China Medical Technologies Invests $345 Million In HPV Genotyping Chip
This article was originally published in PharmAsia News
Executive Summary
China Medical Technologies is acquiring a human papillomavirus genotyping assay which it expects will generate up to $26.5 million in sales next year
You may also be interested in...
China Medical Technologies To Sell Its HIFU Tumor Therapy Business
SHANGHAI - China Medical Technologies, a provider of in vitro diagnostic products, has signed an agreement to sell its high-intensity focused ultrasound tumor therapy system to its major shareholder
China Medical Technologies To Sell Its HIFU Tumor Therapy Business
SHANGHAI - China Medical Technologies, a provider of in vitro diagnostic products, has signed an agreement to sell its high-intensity focused ultrasound tumor therapy system to its major shareholder
China Medical Technologies Weathers Diagnostic Equipment Sales Decline With Reagent Growth
SHANGHAI - China Medical Technologies, an in vitro diagnostic provider in China, has registered a 67.4 percent year-over-year jump in revenues to 915.7 million yuan ($130.6 million) on the back of reagent business growth for FY2007, despite a decline in diagnostic equipment sales, the company announced June 12